Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-11-002010
Filing Date
2011-03-11
Accepted
2011-03-11 06:22:08
Documents
8
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2202560z10-k.htm 10-K 1199003
2 EX-10.11 a2202560zex-10_11.htm EX-10.11 57535
3 EX-10.36 a2202560zex-10_36.htm EX-10.36 84172
4 EX-23.1 a2202560zex-23_1.htm EX-23.1 2981
5 EX-31.1 a2202560zex-31_1.htm EX-31.1 7760
6 EX-31.2 a2202560zex-31_2.htm EX-31.2 7791
7 EX-32.1 a2202560zex-32_1.htm EX-32.1 4730
8 G537634.JPG g537634.jpg GRAPHIC 66901
  Complete submission text file 0001047469-11-002010.txt   1457106
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33277 | Film No.: 11680155
SIC: 2834 Pharmaceutical Preparations